Total Payments
$10,843
2024 Payments
$2,914
Companies
34
Transactions
507
Medicare Patients
905
Medicare Billing
$84,431
Payment Breakdown by Category
Food & Beverage$10,796 (99.6%)
Education$46.91 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,796 | 506 | 99.6% |
| Education | $46.91 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,487 | 56 | $0 (2024) |
| Alkermes, Inc. | $1,425 | 48 | $0 (2024) |
| ITI, Inc. | $678.49 | 30 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $643.39 | 49 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $630.95 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $577.68 | 16 | $0 (2024) |
| Lundbeck LLC | $508.14 | 35 | $0 (2024) |
| ABBVIE INC. | $503.64 | 32 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $399.95 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $390.15 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,914 | 125 | Otsuka America Pharmaceutical, Inc. ($576.07) |
| 2023 | $3,273 | 129 | Otsuka America Pharmaceutical, Inc. ($502.65) |
| 2022 | $2,086 | 93 | Alkermes, Inc. ($434.62) |
| 2021 | $2,570 | 160 | Otsuka America Pharmaceutical, Inc. ($375.19) |
All Payment Transactions
507 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CNS | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Central Nervous System | ||||||
| 12/02/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $9.19 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Insomnia | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $95.63 | General |
| Category: Central Nervous System | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.72 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 209 | 439 | $78,895 | $23,474 |
| 2022 | 6 | 262 | 440 | $75,985 | $21,474 |
| 2021 | 3 | 216 | 436 | $74,700 | $19,726 |
| 2020 | 3 | 218 | 535 | $94,440 | $19,756 |
Total Patients
905
Total Services
1,850
Medicare Billing
$84,431
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 282 | $56,400 | $17,619 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 136 | $21,760 | $5,630 | 25.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 21 | $735.00 | $224.37 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 191 | $38,200 | $12,344 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 171 | $27,360 | $6,272 | 22.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 12 | 12 | $3,600 | $1,423 | 39.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 21 | $3,270 | $595.41 | 18.2% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 12 | 12 | $2,400 | $490.67 | 20.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 30 | 33 | $1,155 | $348.49 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 186 | $37,200 | $11,443 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 230 | $36,800 | $8,051 | 21.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 20 | 20 | $700.00 | $232.57 | 33.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 132 | 349 | $55,840 | $10,714 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 171 | $34,100 | $7,885 | 23.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $4,500 | $1,158 | 25.7% |
About Deborah Murphy
Deborah Murphy is a Psychiatric/Mental Health healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205830783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deborah Murphy has received a total of $10,843 in payments from pharmaceutical and medical device companies, with $2,914 received in 2024. These payments were reported across 507 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($10,796).
As a Medicare-enrolled provider, Murphy has provided services to 905 Medicare beneficiaries, totaling 1,850 services with total Medicare billing of $84,431. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Wichita, KS
- Active Since 06/13/2005
- Last Updated 07/08/2007
- Taxonomy Code 364SP0808X
- Entity Type Individual
- NPI Number 1205830783
Products in Payments
- REXULTI (Drug) $1,486
- ARISTADA (Drug) $979.96
- CAPLYTA (Drug) $785.18
- INGREZZA (Drug) $643.39
- ABILIFY MAINTENA (Drug) $503.64
- VRAYLAR (Drug) $503.64
- LYBALVI (Drug) $444.91
- TRINTELLIX (Drug) $390.15
- QELBREE (Drug) $385.91
- SPRAVATO (Drug) $352.11
- Austedo XR (Drug) $313.74
- Auvelity (Drug) $297.27
- LATUDA (Drug) $290.99
- QUVIVIQ (Drug) $272.44
- AUSTEDO (Drug) $249.00
- NUPLAZID (Drug) $249.00
- HETLIOZ (Drug) $227.48
- INVEGA SUSTENNA (Drug) $225.57
- JORNAY PM (Drug) $211.80
- APLENZIN (Drug) $211.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Wichita
Hayley Knapp, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $27,642
Psychiatric/Mental Health $27,642
Ashley Melugin, Aprn, APRN
Psychiatric/Mental Health — Payments: $6,749
Psychiatric/Mental Health $6,749
Jacy Barker, Aprn, APRN
Psychiatric/Mental Health — Payments: $6,555
Psychiatric/Mental Health $6,555
Susan Mileham, Arnp, ARNP
Psychiatric/Mental Health — Payments: $6,165
Psychiatric/Mental Health $6,165
Ana Ahrens, Arnp, ARNP
Psychiatric/Mental Health — Payments: $4,332
Psychiatric/Mental Health $4,332
Mary Meeker, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,257
Psychiatric/Mental Health $4,257